GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wuhan Hiteck Biological Pharma Co Ltd (SZSE:300683) » Definitions » PB Ratio

Wuhan Hiteck Biological Pharma Co (SZSE:300683) PB Ratio : 1.19 (As of Jun. 22, 2024)


View and export this data going back to 2017. Start your Free Trial

What is Wuhan Hiteck Biological Pharma Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-06-22), Wuhan Hiteck Biological Pharma Co's share price is ¥22.30. Wuhan Hiteck Biological Pharma Co's Book Value per Share for the quarter that ended in Mar. 2024 was ¥18.81. Hence, Wuhan Hiteck Biological Pharma Co's PB Ratio of today is 1.19.

Good Sign:

Wuhan Hiteck Biological Pharma Co Ltd stock PB Ratio (=1.19) is close to 10-year low of 1.16

The historical rank and industry rank for Wuhan Hiteck Biological Pharma Co's PB Ratio or its related term are showing as below:

SZSE:300683' s PB Ratio Range Over the Past 10 Years
Min: 1.16   Med: 2.13   Max: 6.72
Current: 1.19

During the past 11 years, Wuhan Hiteck Biological Pharma Co's highest PB Ratio was 6.72. The lowest was 1.16. And the median was 2.13.

SZSE:300683's PB Ratio is ranked better than
71.17% of 954 companies
in the Drug Manufacturers industry
Industry Median: 1.895 vs SZSE:300683: 1.19

During the past 12 months, Wuhan Hiteck Biological Pharma Co's average Book Value Per Share Growth Rate was -5.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 4.60% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 3.30% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 15.50% per year.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Wuhan Hiteck Biological Pharma Co was 31.60% per year. The lowest was 1.50% per year. And the median was 14.15% per year.

Back to Basics: PB Ratio


Wuhan Hiteck Biological Pharma Co PB Ratio Historical Data

The historical data trend for Wuhan Hiteck Biological Pharma Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Hiteck Biological Pharma Co PB Ratio Chart

Wuhan Hiteck Biological Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.78 2.47 3.13 1.87 1.91

Wuhan Hiteck Biological Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.86 1.94 1.95 1.91 1.38

Competitive Comparison of Wuhan Hiteck Biological Pharma Co's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Wuhan Hiteck Biological Pharma Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan Hiteck Biological Pharma Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wuhan Hiteck Biological Pharma Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Wuhan Hiteck Biological Pharma Co's PB Ratio falls into.



Wuhan Hiteck Biological Pharma Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Wuhan Hiteck Biological Pharma Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Mar. 2024)
=22.30/18.807
=1.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Wuhan Hiteck Biological Pharma Co  (SZSE:300683) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Wuhan Hiteck Biological Pharma Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Wuhan Hiteck Biological Pharma Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Hiteck Biological Pharma Co (SZSE:300683) Business Description

Traded in Other Exchanges
N/A
Address
Hite Science and Technology Park, Wuhan Economic and Technological Development Zone, Hubei Province, Wuhan, CHN, 430056
Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.
Executives
Yan Jie Director
Li Sheng Qiang Executives

Wuhan Hiteck Biological Pharma Co (SZSE:300683) Headlines

No Headlines